VA Secures Historic $10.44B in Pharmaceutical Price Reductions for Veterans
The Department of Veterans Affairs (VA) has achieved over **$10.44 billion** in pharmaceutical price reductions for FY 2026, significantly enhancing its purchasing power and enabling broader healthcare access for veterans. This success underscores evolving procurement strategies that may impact vendor negotiations and contract opportunities in the pharmaceutical sector.